Another day, another multibillion dollar pharma deal - part 2
Is Hikma Pharmaceuticals the next takeover target in the pharmaceutical sector?
The boys over The Motley Fool certainly seem to think so.
Here is a link to a piece they published this morning outlining why Hikma might be of interest to Mylan, which recently tried to buy Sweden's Meda:..
Register
Register for free to see rest of this article and all public articles from Betaville
Login / RegisterDate: Tuesday, 6 May 2014, 8:13 pm